Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria I Toki

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|December 10, 2020
Hyperprogressive disease: A distinct pattern of progression to immune checkpoint inhibitorsMaria I Toki, Nikos Syrigos, Kostas Syrigos
Lung Cancer (Amsterdam, Netherlands)|June 14, 2020
The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision makingMaria I Toki, Kevin Harrington, Konstantinos N Syrigos
Expert Opinion on Drug Safety|October 14, 2014
Hypersensitivity reactions associated with oxaliplatin and their clinical managementMaria I Toki, Muhammad Wasif Saif, Kostantinos N Syrigos
JOP : Journal of the Pancreas|March 13, 2014
The role of biliary drainage in patients with pancreatic adenocarcinomaMaria I Toki, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 31, 2014
Risk determination for pancreatic cancerMaria I Toki, Konstantinos N Syrigos, Muhammad Wasif Saif
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Proof of the quantitative potential of immunofluorescence by mass spectrometryMaria I Toki, Fabiola Cecchi, Todd Hembrough, et al.
Precision Clinical Medicine|June 13, 2022
Benign lymph node microenvironment is associated with response to immunotherapyMaria I Toki, Deepika Kumar, Fahad S Ahmed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2018
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC MutationsMaria I Toki, Nikita Mani, James W Smithy, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|December 10, 2020
Hyperprogressive disease: A distinct pattern of progression to immune checkpoint inhibitorsMaria I Toki, Nikos Syrigos, Kostas Syrigos
Lung Cancer (Amsterdam, Netherlands)|June 14, 2020
The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision makingMaria I Toki, Kevin Harrington, Konstantinos N Syrigos
Expert Opinion on Drug Safety|October 14, 2014
Hypersensitivity reactions associated with oxaliplatin and their clinical managementMaria I Toki, Muhammad Wasif Saif, Kostantinos N Syrigos
JOP : Journal of the Pancreas|March 13, 2014
The role of biliary drainage in patients with pancreatic adenocarcinomaMaria I Toki, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 31, 2014
Risk determination for pancreatic cancerMaria I Toki, Konstantinos N Syrigos, Muhammad Wasif Saif
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Proof of the quantitative potential of immunofluorescence by mass spectrometryMaria I Toki, Fabiola Cecchi, Todd Hembrough, et al.
Precision Clinical Medicine|June 13, 2022
Benign lymph node microenvironment is associated with response to immunotherapyMaria I Toki, Deepika Kumar, Fahad S Ahmed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2018
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC MutationsMaria I Toki, Nikita Mani, James W Smithy, et al.
Pageof 2